RESUMEN
Abstract: Chronic kidney disease (CKD) is the existence of abnormalities in renal structure or function with an impact on health. This is usually considered when estimated glomerular filtration (eGF) falls under 60 mL/min/1.73m2. Its clinical course leads to renal replacement therapy (dialysis or transplant) when eGF falls under 15 mL/min/1.73m2. Screening in at risk populations has been proven to be cost-effective. The aim of this work is to perform CKD screening in the community pharmacy. In this publication we report and justify the methodology in detail. Methodology: Pharmacists from the community pharmacies taking part selected patients who complied with inclusion and not exclusion criteria. Creatinine was measured by means of a finger prick and eGF calculated with the formula CKD-EPI. If this is lower than a set value, which depends on age, referral to the general practitioner takes place. Results: A total of 141 out of 200 pharmacies took part in the study. In all 2116 patients were recruited and 116 patients were lost. The final sample size was 2000 patients. Discussion: The protocol was successfully implemented by community pharmacists and was extremely well received by community pharmacy users. The age adjustment for eGF thresholds provides a novel additional filter. The aim is not to overburden primary care centres with potential referrals of false positives. Confirmation of the diagnosis is subject to voluntary communication by the patient to the pharmacist.
RESUMEN
Exceptional dispensing is "the possibility of safeguarding the spirit of the prescription by the pharmacist in which, when faced with an emergency situation or need, he/she dispenses the most appropriate medication within the real possibilities available in order to guarantee the patient the availability and appropriate use of his/her medication according to the patient and his/her needs".For different reasons, there are problems with the supply of some medicines, which is a problem for the patient.SEFAC has decided to investigate this problem. In this issue we publish the results of a study carried out in November 2021 in two autonomous communities that serves as a pilot for another study called RISK FACTORS THAT HINDER ACCESS TO MEDICATIONS IN THE DISPENSING IN THE COMMUNITY PHARMACY (FRAMEFAC) whose results will be presented at the next congress of community pharmacists (Las Palmas de Gran Canaria, May 2024).Subsequently, SEFAC will make a concrete proposal to solve this problem by means of exceptional dispensing, as is already happening in other countries in our environment.
RESUMEN
La prescripción complementaria es una actividad cada vez más extendida entre los sanitarios no médicos de los países anglosajones. El presente artículo plantea la posibilidad de implantar este servicio en España en la farmacia comunitaria caracterizando cuáles serían los posibles beneficios de este tipo de intervención y en qué casos. Finalmente plantea qué tipo de barreras o cuestiones habría que superar para poder llevarla a cabo
Complementary prescriptions are increasingly widespread among non-medical healthcare professionals in Anglo-Saxon countries. This article presents the possibility of introducing this service in Spain in community pharmacies, specifying the possible benefits of this type of intervention and for which cases. Finally, the types of barriers or issues that would need to be addressed in order to implement it